"SH are the closest thing to having an extended in-house legal team. Their commercial advice fits seamlessly into our business."

Chambers UK 2012

"It's the teamwork which impresses most. It's a seamless and effective operation and there's no other team I'd rather work with."

Chambers Asia-Pacific 2012

"A fabulous presence in Asia"

Legal 500 UK 2012

20

PeopleAndrew Edge

Andrew Edge

Incredibly pragmatic, a great sounding board and the ideal partner for our business

Chambers UK 2012

Andrew is a corporate partner who advises on public and private M&A, joint ventures and equity fundraisings.

Andrew was the lead partner working on the deal that was shortlisted for corporate deal of the year 2010/11 by Legal Business magazine and is ranked both as a leading M&A lawyer and a leading life sciences M&A lawyer by the Chambers & Partners' legal guide.

Transactions on which Andrew has advised include: Andrew’s recent transactions include advising the following companies; Cofely on a £190m acquisition of Balfour Beatty Workplace; Baker Tilly on the acquisition of the assets of RSM Tenon plc by way of a pre-pack administration; BTG plc on the acquisition of EKOS Corporation for $180m; Tristan Capital on the joint venture with Allianz to acquire Warsaw Financial Centre; Piramal Healthcare on the $3.8 billion disposal of its generic branded prescription pharmaceuticals division to Abbott; BTG plc on the £177 million public takeover of Biocompatibles International plc; Lavendon Group plc on the successful defence against a hostile approach from TVH Services NV and Ashtead Group plc; and Commerzbank on the disposal of Kleinwort Benson to RHJ International.

Andrew has been highlighted as a leading lawyer in his field in the 2012 'The Lawyer Hot 100' report. To see a copy of the report, please click here.

Specialist areas

    Contact Andrew

    Stephenson Harwood LLP
    1 Finsbury Circus
    London
    EC2M 7SH
    United Kingdom

    Find us >

    T: +44 20 7809 2102

    Email Andrew